DEXAMETHASONE ACETATE - Generic Drug Details
What are the generic drug sources for dexamethasone acetate and what is the scope of freedom to operate?
Dexamethasone acetate
is the generic ingredient in two branded drugs marketed by Merck, Watson Labs, and Watson Labs Teva, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for DEXAMETHASONE ACETATE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 87 |
| Patent Applications: | 495 |
| DailyMed Link: | DEXAMETHASONE ACETATE at DailyMed |
Recent Clinical Trials for DEXAMETHASONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tianjin Cancer Hospital Airport Hospital | PHASE4 |
| Shaanxi Provincial Cancer Hospital | PHASE4 |
| The First Affiliated Hospital of Henan University of Science & Technology | PHASE4 |
Anatomical Therapeutic Chemical (ATC) Classes for DEXAMETHASONE ACETATE
US Patents and Regulatory Information for DEXAMETHASONE ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Teva | DEXAMETHASONE ACETATE | dexamethasone acetate | INJECTABLE;INJECTION | 087711-001 | May 24, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | DEXAMETHASONE ACETATE | dexamethasone acetate | INJECTABLE;INJECTION | 084315-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Merck | DECADRON-LA | dexamethasone acetate | INJECTABLE;INJECTION | 016675-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
